FORMULA PHARMACEUTICALS
Formula Pharmaceuticals, Inc. is a privately-held, oncology focused company developing unique Chimeric Antigen Receptor (“CAR”) immunotherapies to address critical unmet medical needs in cancer. Distinctive from existing CAR-T approaches, Formula leverages an ALLOGENEIC source, NON-viral tranfection and a differentiated immune effector cell, called Cytokine Induced Killer (C.I.K.) cell. Formula has assembled a world-class scientific, clinical development and business team well positioned to maximize the clinical and commercial value of promising drug candidates through excellence in drug development and strategic partnering.
FORMULA PHARMACEUTICALS
Social Links:
Industry:
Biotechnology
Founded:
2009-01-01
Address:
Berwyn, Pennsylvania, United States
Country:
United States
Website Url:
http://www.formulapharma.com
Total Employee:
11+
Status:
Active
Contact:
610-727-4172
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome IPv6 Contact Form 7 Cloudflare
Similar Organizations
AmberGen
AmberGen missions is to innovate in the area of therapeutics and diagnostics by solving key problems that limit progress in medicine.
Amring Pharmaceuticals
Amring Pharmaceuticals is a privately-held niche generic pharmaceutical company active in global markets.
Basilea Pharmaceutica
Basilea Pharmaceutica Ltd. is a commercial stage biopharmaceutical company.
Breckenridge Pharmaceutical
Breckenridge Pharmaceutical, Inc. is a privately-held member of the Esteve Group.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Founder
Official Site Inspections
http://www.formulapharma.com
- Host name: 104.21.17.202
- IP address: 104.21.17.202
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Formula Pharmaceuticals"
Formula Pharmaceuticals - Crunchbase Company Profile & Funding
Formula Pharmaceuticals, Inc. is a privately-held, oncology focused company developing unique Chimeric Antigen Receptor (“CAR”) immunotherapies to address critical unmet medical needs …See details»
Formula Pharmaceuticals 2025 Company Profile: …
Information on acquisition, funding, investors, and executives for Formula Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
Formula Pharmaceuticals - VentureRadar
Formula Pharmaceuticals VentureRadar profile. Find out more about Formula Pharmaceuticals , Oncology Drug Development, Oncology, DNA, RNA and Peptide Therapies and .See details»
Formula Pharmaceuticals - Products, Competitors, Financials, …
Formula Pharmaceuticals is an immuno-oncology focused company that concentrates on CAR immunotherapy. Use the CB Insights Platform to explore Formula Pharmaceuticals's full profile.See details»
Formula Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Formula Pharmaceuticals, Inc. Subsidiary Company | 2009 | Pennsylvania, United States | 10-50 | www.formulapharma.com Last update 01 Apr 2024 Overview Pipeline Deal Translational …See details»
Formula Pharma - Company Profile - Tracxn
Formula Pharma - Chimeric antigen Receptor (CAR) immunotherapies to treat different types of cancers.. Acquired by CoImmune. Raised a total funding of $1.5M over 1 round from 1 investor.See details»
Formula Pharmaceuticals - Owler
Formula Pharmaceuticals’s Profile, Revenue and Employees. Formula Pharmaceuticals is a biopharmaceutical company that develops Chimeric Antigen Receptor immunotherapy. …See details»
Formula Pharmaceuticals, Inc.:Company Profile & Technical …
Formula Pharmaceuticals is a company that provides Immunotherapy, Chimeric antigen receptor, Immune effector cell and more. Formula Pharmaceuticals is headquartered in United States …See details»
Formula Pharmaceuticals, Inc. - CAGE.report
Dec 13, 2011 DUNS registration and contact information for . Location, website, and products offered. Doing business asSee details»
formulapharma.com - Formula Pharmaceuticals Cameli... - Formula …
Formulapharma.com most likely does not offer any malicious content.See details»
Formula Pharmaceuticals CEO, Founder, Key Executive Team, …
Explore {Formula Pharmaceuticals's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Formula Pharmaceuticals, Inc. (Formula Pharmaceuticals, Inc.) - 药 …
了解Formula Pharmaceuticals, Inc. (Formula Pharmaceuticals, Inc.)公司的药物管线，治疗领域，技术平台，以及它的4篇新闻，疾病领域:血液及淋巴系统疾病，肿瘤，免疫系统疾病，技术 …See details»
"FORMULA PHARMA" LLC: owners, founders, management, details …
Examining the counterparty "FORMULA PHARMA" LLC, TIN 7730246610: when the organization was created, who founded it, what the authorized capital is, who is currently in charge, …See details»
Formula Pharmaceuticals-动脉网 - vbdata.cn
Formula Pharmaceuticals, Inc. 是一家私营的、专注于肿瘤学的公司，开发独特的嵌合抗原受体 (“CAR”) 免疫疗法，以满足癌症中未得到满足的关键医疗需求。与现有的 CAR-T 方法不 …See details»
Formula Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Explore Formula Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 2 news, Disease Domain:Hemic and Lymphatic Diseases, Neoplasms, Immune …See details»
CoImmune acquires Formula Pharmaceuticals - 2020-01-16
Announced Date Jan 16, 2020 Acquisition Type Acquisition Acquisition Status Complete Disposition of Acquired Organization SubsidiarySee details»
formulapharma - GitHub
People This organization has no public members. You must be a member to see who’s a part of this organization.GitHub is where formulapharma builds software.See details»
What is Formula Pharmaceuticals? Company Culture, Mission, Values
See what employees say it's like to work at Formula Pharmaceuticals. Salaries, reviews, and more - all posted by employees working at Formula Pharmaceuticals.See details»
Formula Pharmazeutische und chemische Entwicklungs GmbH
Find company research, competitor information, contact details & financial data for Formula Pharmazeutische und chemische Entwicklungs GmbH of Berlin, Berlin. Get the latest business …See details»
RFK Jr.'s HHS and FDA announce baby formula review | NewsNation
6 days ago The effort, dubbed “Operation Stork Speed,” aims to ensure “quality, safety, nutritional adequacy, and resilience” of infant formula in the U.S.See details»